These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
2388 related items for PubMed ID: 23674577
1. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy. Berthet L, Cochet A, Kanoun S, Berriolo-Riedinger A, Humbert O, Toubeau M, Dygai-Cochet I, Legouge C, Casasnovas O, Brunotte F. J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577 [Abstract] [Full Text] [Related]
3. Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise? Adams HJ, Kwee TC, Fijnheer R, Dubois SV, Nievelstein RA, de Klerk JM. Acta Radiol; 2015 Oct; 56(10):1230-5. PubMed ID: 25387723 [Abstract] [Full Text] [Related]
6. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy. Teagle AR, Barton H, Charles-Edwards E, Dizdarevic S, Chevassut T. Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828 [Abstract] [Full Text] [Related]
8. Utility of Bone Marrow Biopsy and Aspirate for Staging of Diffuse Large B Cell Lymphoma in the Era of Positron Emission Tomography With 2-Deoxy-2-[Fluorine-18]fluoro-deoxyglucose Integrated With Computed Tomography. Vishnu P, Wingerson A, Lee M, Mandelson MT, Aboulafia DM. Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):631-636. PubMed ID: 28684378 [Abstract] [Full Text] [Related]
9. Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using 18F-FDG PET/CT and/or routine iliac crest biopsy? A new approach of PET/CT-guided targeted bone marrow biopsy. Hao B, Zhao L, Luo NN, Ruan D, Pang YZ, Guo W, Fu H, Guo XY, Luo ZM, Wu J, Chen HJ, Wu H, Sun L. BMC Cancer; 2018 Nov 29; 18(1):1192. PubMed ID: 30497426 [Abstract] [Full Text] [Related]
10. 18F-FDG PET-CT imaging versus bone marrow biopsy in pediatric Hodgkin's lymphoma: a quantitative assessment of marrow uptake and novel insights into clinical implications of marrow involvement. Hassan A, Siddique M, Bashir H, Riaz S, Wali R, Mahreen A, Nawaz MK. Eur J Nucl Med Mol Imaging; 2017 Jul 29; 44(7):1198-1206. PubMed ID: 28229191 [Abstract] [Full Text] [Related]
12. Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma. Hong J, Lee Y, Park Y, Kim SG, Hwang KH, Park SH, Jeong J, Kim KH, Ahn JY, Park S, Park J, Lee JH. Ann Hematol; 2012 May 29; 91(5):687-695. PubMed ID: 22008868 [Abstract] [Full Text] [Related]
15. The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET/CT: a Danish-Canadian study. Alzahrani M, El-Galaly TC, Hutchings M, Hansen JW, Loft A, Johnsen HE, Iyer V, Wilson D, Sehn LH, Savage KJ, Connors JM, Gascoyne RD, Johansen P, Clasen-Linde E, Brown P, Villa D. Ann Oncol; 2016 Jun 29; 27(6):1095-1099. PubMed ID: 27002106 [Abstract] [Full Text] [Related]
19. Role of F-18 FDG PET/CT in assessing bone marrow involvement in pediatric Hodgkin's lymphoma. Agrawal K, Mittal BR, Bansal D, Varma N, Srinivasan R, Trehan A, Manohar K, Kashyap R, Bhattacharya A, Marwaha RK. Ann Nucl Med; 2013 Feb 29; 27(2):146-51. PubMed ID: 23143537 [Abstract] [Full Text] [Related]
20. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma. Cho SF, Chang CC, Liu YC, Chang CS, Hsiao HH, Liu TC, Huang CT, Lin SF. Kaohsiung J Med Sci; 2015 Mar 29; 31(3):130-7. PubMed ID: 25744235 [Abstract] [Full Text] [Related] Page: [Next] [New Search]